免疫系统
内体
癌症研究
生物
PD-L1
癌细胞
细胞生物学
T细胞
癌症
CD8型
细胞毒性T细胞
免疫疗法
化学
免疫学
体外
生物化学
细胞内
遗传学
作者
Nuoqing Weng,Chuzhou Zhou,Yuhang Zhou,Yanping Zhong,Zhe Jia,Xionghui Rao,Huaiyu Qiu,Guangyan Zeng,Xinghan Jin,Jianbao Zhang,Zhehong Zhuang,Zhihao Liang,Yuan Deng,Qinghai Li,Shasha Yang,Huixing Luo,Hui‐Yun Wang,Xiaobin Wu
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2024-01-09
卷期号:584: 216618-216618
被引量:5
标识
DOI:10.1016/j.canlet.2024.216618
摘要
As an immune checkpoint protein expressed by diverse cancer cells, programmed death ligand 1 (PD-L1) facilitates immune evasion by interacting with programmed cell death-1 (PD-1) on T cells. Despite the clinical benefits observed in various cancer types, strategies targeting PD-1/PD-L1 have demonstrated limited efficacy in gastric cancer (GC). Furthermore, the regulation of PD-L1, especially at post-translational modification levels, remains largely unknown. Therefore, it is crucial to elucidate the mechanisms governing PD-L1 expression to enhance anti-tumor immunity. In this study, we have identified that IKAROS family zinc finger 4 (IKZF4) and Non-POU domain-containing octamer-binding (NONO) synergistically regulate and enhance the expression of RAB11 family-interacting protein 3 (RAB11FIP3) in GC. The IKZF4/NONO-RAB11FIP3 axis facilitates the endosomal recycling of PD-L1, particularly on the cell membrane of GC cells. Moreover, overexpression of RAB11FIP3 mitigates the hypo-expression of PD-L1 protein resulting from IKZF4 or NONO deletion. Functionally, the silencing of RAB11FIP3 or IKZF4 promotes T cell proliferation, and enhances T-cell cytotoxicity towards GC cells in vitro, which further inhibits tumor immune evasion in mice via increasing the infiltration of CD8
科研通智能强力驱动
Strongly Powered by AbleSci AI